stockrow
Friday 6 November 2026
Export PRPO’s income statement to Excel — free account
Precipio, Inc.
PRPO Healthcare Diagnostics & Research
Precipio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $24.0 million, up 29.8% from fiscal 2024.
- Revenue
- +24.2%
- EPS
- −340.0%
- Free cash flow
- +79.6%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
18.90
0.31
+1.67%
Follow PRPO
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 2 | 3 | 5 | 4 | 6 | 3 | 5 | 5 | 6 |
Altman Z-Score |
(25.91) | (3.56) | (5.62) | (5.11) | (2.90) | (0.64) | (5.99) | (6.73) | (7.23) | (2.40) |
P/S ratio |
2.14 | 3.10 | 1.16 | 3.73 | 5.60 | 3.77 | 1.50 | 0.56 | 0.44 | 1.53 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 48.62 | 102.74 |
Altman Z″-Score (non-manufacturers) |
(75.76) | (8.63) | (14.74) | (12.60) | (12.10) | (4.28) | (14.23) | (16.18) | (19.04) | (13.13) |
Beneish M-Score |
(10.32) | 27.99 | (3.74) | (3.33) | (2.94) | (2.91) | (3.03) | (2.82) | (4.23) | (1.62) |
P/Operating CF |
(11.65) | (2.42) | (1.71) | (5.46) | (23.51) | (23.13) | (9.39) | 74.12 | 14.37 | 100.78 |
P/B ratio |
0.00 | 0.41 | 0.54 | 0.88 | 2.41 | 1.35 | 0.86 | 0.59 | 0.67 | 2.53 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.37 | 5.42 | 5.24 | 36.08 | 10.13 |
EV/Sales |
4.83 | 4.91 | 2.79 | 3.71 | 5.35 | 2.49 | 1.18 | 0.48 | 0.40 | 1.46 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.40 |
EV/Operating CF |
(8.68) | (1.26) | (1.18) | (1.27) | (4.38) | (3.35) | (1.44) | (2.05) | 16.97 | 51.19 |
EV/FCF |
(7.10) | (1.23) | (1.17) | (1.26) | (4.33) | (3.03) | (1.39) | (1.98) | 44.62 | 97.67 |
Quick Ratio |
0.15 | 0.11 | 0.08 | 0.33 | 0.76 | 2.94 | 1.03 | 0.89 | 0.51 | 1.24 |
Current Ratio |
0.18 | 0.17 | 0.13 | 0.43 | 0.90 | 3.20 | 1.31 | 1.17 | 0.81 | 1.61 |
Net Debt/EBITDA |
(2.96) | (0.87) | (0.58) | 0.01 | 0.20 | 1.39 | 0.27 | 0.19 | 0.25 | (3.30) |
Debt/Assets |
556.41% | 12.95% | 23.36% | 4.00% | 5.44% | 1.13% | 2.13% | 1.98% | 4.25% | 3.88% |
Debt/Equity |
(0.73) | 0.27 | 0.82 | 0.06 | 0.08 | 0.01 | 0.03 | 0.02 | 0.06 | 0.06 |
Asset Turnover |
0.61 | 0.12 | 0.12 | 0.15 | 0.30 | 0.35 | 0.36 | 0.77 | 1.06 | 1.26 |
Operating CF/Net income |
0.23 | 0.20 | 0.34 | 0.69 | 0.53 | 0.77 | 0.63 | 0.61 | (0.10) | (1.89) |
Capex/Depreciation |
0.00 | (0.01) | (0.02) | (0.02) | (0.06) | (0.47) | (0.18) | (0.08) | (0.15) | (0.19) |
Interest Coverage |
(3.30) | (6.67) | (51.72) | (23.24) | (19.46) | (480.65) | (1,066.42) | (423.33) | (56.97) | (16.47) |
| 42.24% | (1,012.93%) | (208.02%) | (137.03%) | (102.09%) | (44.01%) | (59.57%) | (38.01%) | (32.35%) | (2.72%) | |
| (144.29%) | (236.35%) | (81.51%) | (64.42%) | (69.46%) | (33.35%) | (46.99%) | (29.56%) | (24.45%) | (1.89%) | |
ROIC |
0.00% | (60.09%) | (80.58%) | (52.30%) | (45.25%) | (45.24%) | (59.78%) | (35.85%) | (23.06%) | (5.90%) |
Return on Tangible Assets |
187.25% | 418.20% | 173.54% | 653.98% | 7,982.29% | (84.45%) | (548.20%) | (457.27%) | 4,247.52% | (12.04%) |
Average Days of Receivables |
82.19 | 154.64 | 87.94 | 67.00 | 52.37 | 28.75 | 40.18 | 31.25 | 15.74 | 30.11 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.92 | 0.89 | 0.85 | 0.76 | 0.48 | 0.64 | 0.71 | 0.70 | 0.51 |
Share Based Compensation of Revenue |
0.70% | 15.96% | (48.50%) | 8.06% | 11.54% | 21.23% | 33.95% | 10.25% | 8.05% | 5.03% |
Graham Net Nets |
(1.83) | (2.34) | (4.11) | (0.38) | (0.07) | 0.23 | 0.04 | 0.00 | (0.18) | (0.02) |
Graham Number |
12,645.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(58.33%) | (1,252.36%) | (662.08%) | (113.17%) | (50.63%) | (24.68%) | (85.62%) | (73.55%) | (53.07%) | (1.09%) |
Free Cash Flow Yield |
(31.74%) | (128.33%) | (205.67%) | (78.75%) | (22.08%) | (21.78%) | (56.79%) | (43.61%) | 2.06% | 0.97% |
Revenue per Share |
1,230.71 | 111.42 | 39.72 | 10.98 | 7.39 | 8.39 | 8.27 | 11.71 | 12.65 | 14.98 |
Operating CF per Share |
(685.00) | (432.62) | (93.68) | (32.10) | (9.02) | (6.23) | (6.79) | (2.74) | 0.30 | 0.43 |
Capex per Share |
0.00 | (9.25) | (1.35) | (0.19) | (0.12) | (0.65) | (0.24) | (0.10) | (0.15) | (0.20) |
Free Cash Flow per Share |
(685.00) | (441.86) | (95.02) | (32.29) | (9.14) | (6.88) | (7.03) | (2.84) | 0.15 | 0.22 |
Cash per Share |
36.43 | 27.22 | 5.28 | 2.98 | 3.22 | 11.06 | 3.03 | 1.16 | 0.95 | 1.65 |
Shareholders Equity per Share |
(4,614.29) | 842.28 | 84.92 | 46.37 | 17.19 | 23.32 | 14.39 | 11.12 | 8.25 | 9.07 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(4,614.29) | 842.28 | 84.92 | 46.37 | 17.19 | 23.32 | 14.39 | 11.12 | 8.25 | 9.07 |
Free Cash Flow |
(0.96) | (6.83) | (6.85) | (9.20) | (7.53) | (7.26) | (8.00) | (3.68) | 0.22 | 0.36 |
Working Capital |
(2.46) | (8.29) | (11.97) | (2.46) | (0.45) | 9.27 | 1.35 | 0.54 | (0.82) | 2.29 |
Capital Expenditures |
— | (0.14) | (0.10) | (0.05) | (0.10) | (0.68) | (0.28) | (0.13) | (0.22) | (0.33) |
Net Current Asset Value |
(6.75) | (12.49) | (13.69) | (4.43) | (2.35) | 7.64 | 0.57 | 0.01 | (1.45) | (0.72) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.08 | 0.03 | 0.02 | 0.02 | 0.08 | 0.03 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.52 | 33.87 | 11.95 | 7.22 | 6.05 | 1.73 | 1.74 | 2.06 | 2.11 | 2.41 |
Cash ROIC |
55.63% | (40.25%) | (59.31%) | (62.00%) | (41.96%) | (19.82%) | (39.46%) | (22.62%) | 1.52% | 1.99% |
Accounts Receivable Turnover |
5.29 | 3.08 | 4.03 | 4.95 | 8.41 | 11.27 | 10.86 | 13.01 | 17.65 | 17.28 |
Accounts Payable Turnover |
0.40 | 0.46 | 0.51 | 0.82 | 2.72 | 3.63 | 3.54 | 6.89 | 17.70 | 15.26 |
Inventory Turnover |
12.93 | 10.97 | 14.74 | 15.27 | 18.51 | 14.13 | 10.85 | 16.81 | 19.81 | 16.09 |
Average Days of Payables |
407.90 | 1,301.60 | 714.92 | 243.00 | 125.04 | 105.31 | 107.99 | 24.73 | 20.56 | 30.94 |
Days of Inventory on Hand |
37.63 | 41.07 | 27.25 | 23.09 | 25.85 | 31.88 | 37.44 | 15.27 | 24.08 | 25.58 |
Average Receivables |
0.33 | 0.56 | 0.71 | 0.63 | 0.72 | 0.79 | 0.87 | 1.17 | 1.05 | 1.39 |
Average Payables |
2.43 | 3.09 | 5.14 | 3.55 | 1.81 | 1.78 | 1.95 | 1.33 | 0.62 | 0.87 |
Average Inventory |
0.08 | 0.13 | 0.18 | 0.19 | 0.27 | 0.46 | 0.64 | 0.55 | 0.55 | 0.83 |
Average Assets |
2.83 | 14.05 | 24.43 | 20.56 | 20.11 | 25.58 | 25.97 | 19.80 | 17.55 | 19.16 |
Average Common Equity |
(9.66) | 3.28 | 9.57 | 9.66 | 13.68 | 19.38 | 20.49 | 15.40 | 13.26 | 13.33 |
Columns are period end dates · fundamentals updated 26 Oct 2026